Sulfated alginate based complex for sustained calcitonin delivery and enhanced osteogenesis

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Regenerative Medicine

Background:

• Direct administration of salmon calcitonin (sCT) via injection has limited efficacy due to poor bioavailability.
• There is a critical need for advanced drug delivery systems that provide sustained release and preserve the bioactivity of therapeutic proteins like sCT.
• Developing cost-effective and efficient carriers for clinical applications remains a significant challenge.

Purpose of the Study:

• To develop a simple and effective alginate-based complex for sustained delivery of salmon calcitonin (sCT).
• To evaluate the release kinetics, bioactivity, biocompatibility, and osteogenic potential of the novel sCT delivery system.

Main Methods:

• Construction of an alginate/alginate sulfate-sCT (Alg/AlgS-sCT) complex utilizing electrostatic interactions.
• In vitro assessment of sCT release profile over 15 days.
• Evaluation of sCT bioactivity and conformational integrity post-release.
• In vitro biocompatibility testing using MC3T3 cells.
• Assessment of the osteogenic potential by measuring alkaline phosphatase activity and calcium ion concentrations.

Main Results:

• The Alg/AlgS-sCT complex demonstrated sustained release of sCT for up to 15 days, significantly longer than pure sCT (2 days).
• The released sCT retained its bioactivity, indicating a stable conformation similar to native sCT.
• In vitro studies confirmed the complex's biocompatibility.
• The combination of alginate sulfate and sCT synergistically enhanced the osteogenic capacity of MC3T3 cells, evidenced by increased alkaline phosphatase levels and calcium ion accumulation.

Conclusions:

• The developed Alg/AlgS-sCT complex represents a simple, economical, and effective system for sustained salmon calcitonin delivery.
• This system preserves sCT bioactivity over an extended period and demonstrates significant potential for enhancing osteogenesis.
• The findings suggest promising clinical applications and offer a blueprint for designing other protein-based drug delivery systems.